Answers are grounded in this paper and cite their sources.
The purpose of this study was to describe the occurrence of the M184V mutation in a single clinic setting over a period of 10 years. We examined the combination Antiretroviral Therapy (cART) being taken at the time of first identification of the M184V mutation as well as Second Line Regimens (SLR) started immediately after the documentation of M184V. SLR were evaluated for frequency and time to Virologic Suppression (VS) as well as frequency and time to subsequent Virologic Failure (VF). Design: This was a retrospective cohort study of all Human Immunodeficiency Virus (HIV)infected patients receiving care at the Washington
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: